Skip to: Content
Skip to: Site Navigation
Skip to: Search
WEDNESDAY, NOVEMBER 25, 2009
| Subscribe to Newser's RSS feeds RSS | Follow Newser on Twitter Twitter

NEWS ABOUT: GlaxoSmithKline

GlaxoSmithKline stories: 23 news summaries

21 - 23 of 23 Stories | << Prev 1 2

Switch to grid view »

FDA Warned of Avandia Risks Years Ago

Doctor alerted agency to cardiovascular concerns in 2000

May 24, 07 1:56 PM CDT
(Newser) - A diabetes doctor warned the FDA of heart risks posed by the diabetes drug Avandia seven years ago, the New York Times reports. The same concerns raised by Dr. John Buse in a 2000 letter were reiterated in a study published by cardiologist Steven Nissen this week. More »

MORE ABOUT:
health • diabetes • GlaxoSmithKline • Avandia • pharma • John Buse

Drug Company Nemesis
Strikes Again

Crusading cardiologist took on Vioxx, now Avandia, for heart risks

May 22, 07 1:32 PM CDT
(Newser) - The doctor who helped to raise concerns about the painkiller Vioxx is back—with the study released earlier this week linking the same company's popular diabetes drug, Avandia, to higher risk of heart attacks. The Wall Street Journal looks at 58-year-old cardiologist Steven Nissen's role in identifying and publicizing drug... More »

MORE ABOUT:
medicine • FDA • drugs • diabetes • pharmaceutical companies • GlaxoSmithKline • Avandia • Steven Nissen • Vioxx

Diabetes
Drug Ups
Heart Risk

New study documents dangers of Avandia, but company nixes recall

May 21, 07 3:15 PM CDT
(Newser) - A popular diabetes drug may increase heart attack risks, a study reported in the New England Journal of Medicine concludes. Patients who took Avandia, which treats Type 2 diabetes, were 43% more likely to have a heart attack than those who took a placebo, the Cleveland Clinic study found. More »

MORE ABOUT:
medicine • FDA • health • diabetes • pharmaceutical companies • GlaxoSmithKline • Avandia • pharma • medical research • heart attack

21 - 23 of 23 Stories | << Prev 1 2


from our news partners